Experience

Bin Wang

    • EpimAb and Innovent Enter $120 Million Bispecific Antibody Partnership 


    • Eiger + Celladon Sign Merger Agreement 


    • Medivation Expanding Oncology Franchise with Acquisition of Talazoparib from BioMarin 


    • KemPharm Completes its IPO 


    • Nexvet Biopharma Closes Initial Public Offering 


    • Atara – $63 Million IPO and Follow-On Offerings 


    • Adamas Pharmaceuticals Initial Public Offering 


    • Versartis $145 Million IPO 


    • Jazz Pharmaceuticals $125 Million Acquisition of ADX-N05 


    • Portola Pharmaceuticals $140 Million IPO